Showing results 1 to 20 of 23
next >
| Issue Date | Title | Author(s) |
| 2022 | Adding pneumatic compression therapy in lower extremity lymphedema increases compliance of treatment, while decreasing the infection rate | Soran, Atilla; Toktaş, Osman; Grassi, Ariel; Sezgin, Efe |
| Oct-2022 | ASO visual abstract: Intervention for hepatic and pulmonary METastases in breast cancer patients-prospective, multi-institutional registry study: IMET; Protocol MF 14-02 | Soran, Atilla; Özbaş, Serdar; Özçınar, Beyza; Işık, Arda; Doğan, L.; Şenol, Kazım; Dağ, Ahmet; Karanlık, Hasan; Aytaç, Özgür; Karadeniz Çakmak, Güldeniz; Dalcı, Kubilay; Doğan, Mutlu; Sezer, Atakan Y.; Gökgöz, Şehsuvar; Özyar, Enis; Sezgin, Efe |
| 2019 | Can post-mastectomy radiation therapy be omitted in T1-2 clinically node-negative breast cancer patients with a positive sentinel lymph node biopsy? | Dinh, Kate; Soran, Atilla; Işık, Arda; McAuliffe, Priscilla; Diego, Emilia; Sezgin, Efe ; Johnson, Ronald |
| 2023 | Correction: Intervention for hepatic and pulmonary metastases in breast cancer patients: Prospective, multi-institutional registry Study–IMET, Protocol MF 14-02 | Soran, Atilla; Özbaş, Serdar; Özçınar, Beyza; Işık, Arda; Doğan, Lütfi; Şenol, Kazım; Sezgin, Efe |
| 2021 | Correspondence to “Locoregional therapy in de novo metastatic breast cancer: Systematic review and meta-analysis, written by Reinhorn D et al. In The Breast Journal 58 (2021) 173–181” | Soran, Atilla; Özbaş, Serdar; Doğan, Lütfi; Işık, Arda; Sezgin, Efe |
| 2019 | Does locoregional treatment in de novo stage IV bone-only metastatic breast cancer prolong survival? An ongoing multicenter registry study | Soran, Atilla; Işık, Arda; Doğan, Lütfi; Sezgin, Efe ; Özbaş, Serdar |
| 2023 | Early detection of breast cancer-related lymphedema: Accuracy of indocyanine green lymphography compared with bioimpedance spectroscopy and subclinical lymphedema symptoms | Soran, Atilla; Bengur, Fuat Barış; Rodriguez, Wendy; Chroneos, Maria Z.; Sezgin, Efe |
| 2021 | The effect of primary surgery in patients with de novo stage IV breast cancer with bone metastasis only (Protocol BOMET MF 14-01): A multi-center, prospective registry study | Soran, Atilla; Doğan, Lütfi; Işık, Arda; Özbaş, Serdar; Trabulus, Didem Can; Demirci, Umut; Sezgin, Efe |
| 2021 | The effect of primary surgery in patients with stage IV breast cancer with bone metastasis only (protocol bomet MF14-01); a multi-center, registry study | Soran, Atilla; Doğan, Lütfi; Özbaş, Serdar; Işık, Arda; Trablus, D.; Demirci, U.; Sezgin, Efe |
| Jun-2018 | Factors related to recurrence of idiopathic granulomatous mastitis: what do we learn from a multicentre study? | Uysal, Erdal; Soran, Atilla; Sezgin, Efe ; Granulomatous Mastitis Study Group |
| 2016 | The impact of Onco type DX® recurrence score of paraffin-embedded core biopsy tissues in predicting response to neoadjuvant chemotherapy in women with breast cancer | Soran, Atilla; Bhargava, Rohit; Johnson, Ronald; Ahrendt, Gretchen; Bonaventura, Marguerite; Diego, Emilia; McAuliffe, Priscilla F.; Serrano, Merida; Menekşe, Ebru; Sezgin, Efe ; McGuire, Kandace P. |
| Oct-2022 | Intervention for hepatic and pulmonary metastases in breast cancer patients: Prospective, multi-institutional registry Study-IMET, Protocol MF 14-02 | Soran, Atilla; Özbaş, Serdar; Özçınar, Beyza; Işık, Arda; Doğan, Lütfi; Şenol, Kazım; Dağ, Ahmet; Karanlık, Hasan; Aytaç, Özgür; Karadeniz Çakmak, Güldeniz; Dalcı, Kubilay; Doğan, Mutlu; Sezer, Atakan Y.; Gökgöz, Şehsuvar; Özyar, Enis; Sezgin, Efe |
| Apr-2022 | Intervention to hepatic and pulmonary METastases in breast cancer patients: Prospective, multi-institutional registry study-IMET; Protocol MF 14-02 | Soran, Atilla; Özbaş, Serdar; Özçınar, Beyza; Işık, Arda; Doğan, Lütfi; Şenol, Kazım; Dağ, Ahmet; Karanlık, Hasan; Aytaç, Özgür; Karadeniz Çakmak, Güldeniz; Dalcı, Kubilay; Doğan, Mutlu; Sezer, Atakan Y.; Gökgöz, Şehsuvar; Özyar, Enis; Sezgin, Efe |
| 2023 | Locoregional Treatment Improves Survival in De Novo Bone-only Metastatic Breast Cancer: Long-term Results of the Prospective, Multi-institutional Study - Protocol BOMET MF14-01 | Soran, Atilla; Doğan, Lütfi; Işık, Arda; Özbaş, Serdar; Can Trabulus, Didem; Demirci, Umut; Karanlık, Hasan; Sezgin, Efe |
| 2021 | Lymphedema after sentinel lymph node biopsy: Who is at risk? | Işık, Arda; Soran, Atilla; Grasi, Ariel; Barry, Noran; Sezgin, Efe |
| 2021 | A novel first-line treatment alternative for noncomplicated idiopathic granulomatous mastitis: Combined intralesional steroid injection with topical steroid administration | Toktaş, Osman; Konca, Can; Trabulus, Didem Can; Soyder, Aykut; Köksal, Hande; Karanlık, Hasan; Kamalı Polat, Ayfer; Özbaş, Serdar Mustafa; Yormaz, Serdar; Sezgin, Efe ; Soran, Atilla |
| 2020 | Primary surgery in patients with de novo stage IV BC; finalizing the protocol MF07-01 randomized clinical trial | Soran, Atilla; Özmen, Vahit; Özbaş, Serdar; Karanlık, Hasan; Müslümanoğlu, Mahmut; İğci, Abdullah; Sezgin, Efe |
| 2021 | Primary surgery with systemic therapy in patients with de novo stage IV breast cancer: 10-year follow-up; protocol MF07-01 randomized clinical trial | Soran, Atilla; Özmen, Vahit; Özbaş, Serdar; Karanlık, Hasan; Müslümanoğlu, Mahmut; İğci, Abdullah; Cantürk, Nuh Zafer; Utkan, Zafer; Evrensel, Türkkan; Sezgin, Efe |
| 2023 | Primary Tumor Surgery in Patients with De Novo Bone-only Stage IVA/B Breast Cancer: MetS: Protocol MF22-03, Combination Data Analysis of Prospective Studies | Göktepe, Berk; Demirörs, Berkay; Şenol, Kazım; Özbaş, Serdar; Cabıoglu, Neslihan; Sezgin, Efe ; Soran, Atilla |
| 2018 | Randomized trial comparing resection of primary tumor with no surgery in stage IV breast cancer at presentation: Protocol MF07-01 | Soran, Atilla; Özmen, Vahit; Özbaş, Serdar; Karanlık, Hasan; Müslümanoğlu, Mahmut; İgci, Abdullah; Johnson, Ronald; Sezgin, Efe |
